Sheena Bhalla

机构：The University of Texas Southwestern Medical Center · ORCID：0000-0003-0614-9546

发表论文 51 篇 · 总被引 2471 次 · h-index 14

代表论文

• Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer (2023 · Lung Cancer · 被引 42)
• Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations (2024 · Journal of the National Comprehensive Cancer Network · 被引 18)
• Contemporary Trends in Reviewing Test Results Through the Electronic Patient Portal Among Patients With Cancer (2023 · JAMA Oncology · 被引 17)
• Innate and adaptive immune features associated with immune-related adverse events (2025 · Journal for ImmunoTherapy of Cancer · 被引 14)
• Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report (2024 · International Journal of Radiation Oncology*Biology*Physics · 被引 10)
• Emerging Strategies in Lung Cancer Screening: Blood and Beyond (2024 · Clinical Chemistry · 被引 9)